Get more info on this report!Medical Imaging Markets: Contrast AgentsNovember 1, 2009The appli...
research and drug discovery/development. Specific advances in contrast agent-enableddiagnostics for mammography, Alzheimer...
1.2 X-Ray and CT      1.3 Ultrasound      1.4 MRI      1.5 Radiopharmaceuticals      1.6 World Market Summary      1.6.1 M...
2.5 Reimbursement and Other Concerns      2.5.1 Volume Determination      2.5.2 Safety      2.5.3 Combination Technology3....
4.3.1 Market Forecast    4.4 Outlook for Molecular Imaging Agents    4.4.1 Market Forecast5.0 CORPORATE PROFILES      Acus...
MDS Nordion      NanoScan Imaging      Palatin Technologies Inc.      Pharmacyclics      Point Biomedical Corp.      Starp...
Exhibit 16: Worldwide Medical MRI Procedures, 2008Exhibit 17: World Market Geographic Segmentation for Medical MRI Procedu...
Exhibit 37: Selected Molecular Imaging Products       Exhibit 38: World Market for Medical PET Radiopharmaceuticals, 2007-...
Upcoming SlideShare
Loading in …5
×

Medical Imaging Markets: Contrast Agents

1,525 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,525
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
18
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Medical Imaging Markets: Contrast Agents

  1. 1.    Get more info on this report!Medical Imaging Markets: Contrast AgentsNovember 1, 2009The application and versatility of medical imaging modalities are continuing to grow insignificance as the population ages and healthcare costs rise. Examinations that canfacilitate earlier disease diagnosis and the most appropriate treatment are in order. Thisbodes well for contrast media markets.Since our last round-up of the contrast media market, the economic environment in theworld has changed. Although the recession may have caused hospitals, physicianoffices and other institutions to delay or cancel the purchase of imaging equipment, ithas not had a significant negative impact on the use of contrast agents with theequipment already on hand. Specifically, annual growth for medical contrast mediaduring the next five years appears to be strong, despite the recession slowing capitalequipment purchases. Imaging exams are still needed for many diagnoses, andcontrast enhancement facilitates diagnosis in many cases. Kalorama expects growthranges to remain high.This comprehensive study of the world market for contrast agents builds on the previousmodality-focused reports of Kaloramas medical imaging market reports. Coverageincludes: • World and regional revenue forecasts for contrast agents and radiopharmaceuticals by modality through 2012. (X-Ray, CT, Ultrasound, MRI, PET, SPECT) • Market share of the major contrast agent supplers • Procedure volumes by modality and region • Estimates of the portion of procedures in each modality using contrast enhancement • Contrast-enhancement products in developmentThe report also discusses technical developments and emerging application trendssuch as therapeutic monitoring, whole body screening, and guided therapeuticinterventions, and how contrast agents are helping to expand imaging’s role in basic
  2. 2. research and drug discovery/development. Specific advances in contrast agent-enableddiagnostics for mammography, Alzheimer’s, and other indications are also reviewed.The report concludes with profiles of top suppliers and developers including: • Acusphere Inc. • Alseres Pharmaceuticals Inc. • Amag Pharmaceuticals Inc. • Aposense Ltd. • Avid Radiopharmaceuticals Inc. • Bayer Schering Pharma • Bracco SpA • Cell Point • Covidien Ltd. • Daiichi Pharmaceutical Co. Ltd. • Dendritic NanoTechnologies Inc. • Draximage • Endocyte Inc. • Eusa Pharma • GE Healthcare • Guerbet Group • Hovione FarmaCiencia SA • Imcor Pharmaceutical Co. • Immunomedics Inc. • Insight Agents GmbH • King Pharmaceuticals Inc. • Luna nanoWorks • Macrocyclics • MDS Nordion • NanoScan Imaging • Palatin Technologies Inc. • Pharmacyclics • Point Biomedical Corp. • Starpharma Holdings Ltd. • VisEn Medical Inc.Table of Contents1.0 EXECUTIVE SUMMARY 1.1 The Contrast Revolution
  3. 3. 1.2 X-Ray and CT 1.3 Ultrasound 1.4 MRI 1.5 Radiopharmaceuticals 1.6 World Market Summary 1.6.1 Market Drivers and Trends 1.6.2 Market Challenges 1.6.2.1 Generics 1.6.3 World Market Growth Analysis 1.7 Methodology2.0 INTRODUCTION 2.1 Harnessing Science to Optimize Outcomes 2.2 History and Evolution 2.3 Key Markets 2.3.1 X-Ray and CT 2.3.2 Ultrasound 2.3.2.1 Microbubbles 2.3.3 MRI 2.3.3.1 Novel Agents 2.3.4 Nuclear Medicine 2.3.4.1 Diagnostics 2.3.4.2 Sourcing Issues 2.3.4.3 PET 2.3.4.3.1 New Applications 2.3.4.4 SPECT 2.3.4.5 Gamma Cameras 2.4 Ionic and Non-Ionic Contrast
  4. 4. 2.5 Reimbursement and Other Concerns 2.5.1 Volume Determination 2.5.2 Safety 2.5.3 Combination Technology3.0 PROMISING DEVELOPMENTS 3.1 Detecting Prostate Cancer 3.2 Assessing Heart Risk 3.3 Breast Chemo Outcome 3.4 Software Enhancement 3.5 Four in One 3.6 Photoacoustic Tomography 3.7 Carbon Do 3.8 Nanomagnets 3.9 Kidney Damage 3.10 Angiograph 3.11 Iodinated Contras 3.12 Children 3.13 Dynamic Contrast-Enhanced MRI 3.14 Preclinica 3.15 Nanocolloid4.0 MARKET 4.1 Market Drivers 4.1.1 Targeted Imaging 4.1.2 Increasing Specificity 4.1.3 Aging Population 4.2 Utilization 4.2.1 Procedures 4.3 Outlook for Contrast Media
  5. 5. 4.3.1 Market Forecast 4.4 Outlook for Molecular Imaging Agents 4.4.1 Market Forecast5.0 CORPORATE PROFILES Acusphere Inc. Alseres Pharmaceuticals Inc. Amag Pharmaceuticals Inc. Aposense Ltd. Avid Radiopharmaceuticals Inc. Bayer Schering Pharma Bracco SpA Cell>Point Covidien Ltd. Daiichi Pharmaceutical Co. Ltd. Dendritic NanoTechnologies Inc. Draximage Endocyte Inc. Eusa Pharma GE Healthcare Guerbet Group Hovione FarmaCiencia SA Imcor Pharmaceutical Co. Immunomedics Inc. Insight Agents GmbH King Pharmaceuticals Inc. Luna nanoWorks Macrocyclics
  6. 6. MDS Nordion NanoScan Imaging Palatin Technologies Inc. Pharmacyclics Point Biomedical Corp. Starpharma Holdings Ltd. VisEn Medical Inc. LIST OF EXHIBITS1.0 EXECUTIVE SUMMARY Exhibit 1: World Market for X-Ray Medical Contrast Media , 2008-2012 Exhibit 2: World Market for CT Medical Contrast Media 2008-2012 Exhibit 3: World Market for Ultrasound Medical Contrast Media , 2008-2012 Exhibit 4: World Market for MRI Medical Contrast Media 2008-2012 Exhibit 5: World Market for PET Radiopharmaceuticals, 2008-2012 Exhibit 6: World Market for SPECT Radiopharmaceuticals , 2008-20122.0 INTRODUCTION Exhibit 7: Key Medical Contrast Agents by Type Exhibit 8: Advantages of Non-Ionic Contrast Media4.0 MARKETS Exhibit 10: World Market for Medical Contrast Media and Radiopharmaceuticals, 2007-2012 Exhibit 11: World Market Share for Medical Contrast Media and Radiopharmaceuticals, 2009 Exhibit 12: World Market Share for Medical Contrast Media and Radiopharmaceuticals, 2012 Exhibit 13: Key Players’ Percentage Share - Worldwide Medical Contrast Media Market Exhibit 14: World Market Geographic Segmentation for Medical X-Ray Procedures, 2008 Exhibit 15: World Market Geographic Segmentation for Medical X-Ray Procedures, 2008
  7. 7. Exhibit 16: Worldwide Medical MRI Procedures, 2008Exhibit 17: World Market Geographic Segmentation for Medical MRI Procedures,2008Exhibit 18: Worldwide Medical CT Procedures, 2008Exhibit 19: World Market Geographic Segmentation for Medical CT Procedures,2008Exhibit 20: Worldwide Medical Ultrasound Procedures, 2008Exhibit 21: World Market Geographic Segmentation for Medical UltrasoundProcedures, 2008Exhibit 22: Worldwide Medical PET Procedures, 2008Exhibit 23: World Market Geographic Segmentation for Medical PET ProceduresExhibit 24: Status of Selected Medical Imaging AgentsExhibit 25: World Market for X-Ray Contrast Media, 2007-2012Exhibit 26: World Market for Medical X-Ray Contrast Media by GeographicSegment 2007-2012Exhibit 27: World Market for Medical X-Ray Contrast Media by GeographicSegment, 2008Exhibit 28: World Market for Medical CT Contrast Media, 2007-2012Exhibit 29: World Market for Medical CT Contrast Media by GeographicSegment, 2007-2012Exhibit 30: World Market for Medical CT Contrast Media by GeographicSegment, 2008Exhibit 31: World Market for Medical Ultrasound Contrast Media, 2007-2012Exhibit 32: World Market for Medical Ultrasound Contrast Media by GeographicSegment, 2007-2012Exhibit 33: World Market for Medical Ultrasound Contrast Media by GeographicSegment, 2008Exhibit 34: World Market for Medical MRI Contrast Media, 2007-2012Exhibit 35: World Market for Medical MRI Contrast Media by GeographicSegment, 2007-2012Exhibit 36: World Market for Medical MRI Contrast Media by GeographicSegment, 2008
  8. 8. Exhibit 37: Selected Molecular Imaging Products Exhibit 38: World Market for Medical PET Radiopharmaceuticals, 2007-2012 Exhibit 39: World Market for Medical PET Radiopharmaceuticals by Geographic Segment, 2007-2012 Exhibit 40: World Market for Medical PET Radiopharmaceuticals by Geographic Segment, 2008 Exhibit 41: World Market for Medical SPECT Radiopharmaceuticals, 2007-2012 Exhibit 42: World Market for Medical SPECT Radiopharmaceuticals by Geographic Segment, 2007-2012 Exhibit 43: World Market for Medical SPECT Radiopharmaceuticals by Geographic Segment, 2008Available immediately for Online Download athttp://www.marketresearch.com/product/display.asp?productid=2469989  US: 800.298.5699UK +44.207.256.3920Intl: +1.240.747.3093Fax: 240.747.3004 

×